Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 10, 2024
Discovery & Translation
Science Spotlight: As miRNAs get Nobel Prize, targeting advances continue
BioCentury’s roundup of translational innovation also features Vedanta’s solution to GI infection, Takeda’s exon-skipping delivery tech, and more
BioCentury | Sep 14, 2021
Translation in Brief
mRNA combos from BioNTech, Moderna; plus new CRISPR nucleases and more
BioCentury’s roundup of translational news
BioCentury | Jan 21, 2020
Tools & Techniques
Disney lab uncovers another RNA-binding small molecule for triple-negative breast cancer
The Disney lab expands its RNA-binding small molecule toolbox with targeted RNA degradation
BioCentury | Nov 13, 2019
Clinical News
Bardoxolone data set Reata up to advance second compound toward registration
BioCentury | Jul 11, 2018
Translation in Brief
The RNA Renaissance continues
How Disney’s Scripps lab has expanded the RNA target universe
BioCentury | Feb 8, 2018
Translation in Brief
Diverging pathways
Genetic differences in tumors could shed light on disparity in clinical outcomes
Items per page:
1 - 10 of 44